Course offering number:0904-706
Course ID:
2287
Strategies for Leveraging PAT/QbD in Biologic Applications
Pre-recorded Course
AN ON-DEMAND ONLINE TRAINING FORMAT
John E. Carroll, C.Ph.C., President, Carroll Ventures, Inc., Managing Partner, Cadrai Technology Group
John E. Carroll is Managing Partner, Cadrai Technology Group and President, Carroll Ventures, Inc. The Cadrai Technology Group develops and
presents focused training programs for issues germane to the current needs of the pharmaceutical industry including small-molecule, biologic
and nutraceutical preparations. Cadrai has an equally strong focus in both training and business development for the analytical instrument
industry. Among Cadrai successes are: ion-mobility spectrometry for cleaning verification, NIR dedicated to tablet & capsule analysis,
laserinduced breakdown spectroscopy, chemical imaging and automated dissolution.
As Pharmaceutical Business Unit Manager for Perstorp Analytical Instruments (now Foss), Mr. Carroll built a global, sustainable business that
saw over 8,000 NIR test instruments placed within the pharmaceutical manufacturing industry.
Mr. Carroll has a B.A.S in Engineering Technology/Chemistry, an M.B.A. (c) in International Marketing, sixty publications and numerous
technical presentations. He is the author of “The NIR Desk Reference” (Carroll, He and Landa) and “The Handbook of FTIR” (Carroll). He is
also the editor of “IR-MS: High sensitivity and selectivity for organic analysis” (Mattson and Carroll). Professional memberships include AAPS,
ACS, CNIRS and ISPE.
|